Nā huahana
-
Hoʻohui ʻia nā mea maʻi hanu
Hoʻohana ʻia kēia pahu no ka ʻike qualitative o nā pathogens hanu i loko o ka waikawa nucleic i unuhi ʻia mai nā laʻana oropharyngeal swab kanaka.
Hoʻohana ʻia kēia ʻano hoʻohālike no ka ʻike qualitative o 2019-nCoV, influenza A virus, influenza B virus a me respiratory syncytial virus nucleic acids i loko o nā ʻano oropharyngeal swab samples.
-
Hoʻohui ʻia nā mea maʻi hanu
Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o ka maʻi maʻi influenza A, ka maʻi influenza B, ka maʻi hanu syncytial, adenovirus, ka rhinovirus kanaka a me ka mycoplasma pneumoniae nucleic acids i loko o nā swabs nasopharyngeal kanaka a me nā laʻana oropharyngeal swab.Hiki ke hoʻohana ʻia nā hopena hoʻāʻo no ke kōkua ʻana i ka ʻike ʻana i nā maʻi pathogen respiratory, a hāʻawi i ke kumu diagnostic molecular auxiliary no ka maʻi a me ka mālama ʻana i nā maʻi pathogen respiratory.
-
14 Nā ʻano o ka maʻi maʻi maʻi maʻi Genitourinary
Hoʻolālā ʻia ka pahu no ka ʻike in vitro qualitative o Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma hominis (Mh), Herpes simplex virus type 1 (HSV1), Ureaplasma urealyticum (UU), Herpes simplex virus type 2 ( HSV2), Ureaplasma parvum (UP), Mycoplasma genitalium (Mg), Candida albicans (CA), Gardnerella vaginalis (GV), Trichomonal vaginitis (TV), Group B streptococci (GBS), Haemophilus ducreyi (HD), a me Treponema pallidum ( TP) i loko o ke kane urethral swab, wahine cervical swab, a me ka wahine vaginal swab samples, a hāʻawi i ke kōkua i ka ʻike a me ka mālama ʻana i nā maʻi me nā maʻi maʻi genitourinary.
-
SARS-CoV-2/influenza A/influenza B
He kūpono kēia kit no ka ʻike in vitro qualitative o SARS-CoV-2, influenza A a me ka influenza B nucleic acid o ka nasopharyngeal swab a me nā oropharyngeal swab samples o ka poʻe i manaʻo ʻia i ka maʻi o SARS-CoV-2, influenza A a me ka influenza. B. Hiki ke hoʻohana ʻia i ka maʻi pneumonia a me nā hihia puʻupuʻu i manaʻo ʻia a no ka ʻike qualitative a me ka ʻike ʻana i ka SARS-CoV-2, influenza A a me ka influenza B nucleic acid i loko o ka nasopharyngeal swab a me nā oropharyngeal swab samples o ka maʻi coronavirus novel ma nā kūlana ʻē aʻe.
-
14 Nā ʻano o ka maʻi papilloma kanaka kiʻekiʻe (16/18/52 kikokiko)
Hoʻohana ʻia ka pahu no ka ʻike in vitro qualitative o 14 mau ʻano papillomaviruses kanaka (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) mau ʻāpana nucleic acid. i lokokanakanā laʻana mimi, nā laʻana o ka puʻu ʻāʻī o ka ʻōpū wahine, a me nā laʻana o ka puʻu wahine, a me ka HPV 16/18/52ke kākau ʻana, e kōkua i ka ʻike a me ka mālama ʻana i ka maʻi HPV.
-
Kiko Ho'āʻo Prog (Fluorescence Immunoassay)
Hoʻohana ʻia ka pahu no ka in vitro quantitative detection of the concentration ofprogesterone (Prog) i loko o ka serum kanaka, ka plasma a i ʻole nā hōʻailona koko holoʻokoʻa.
-
OXA-23 Carbapenemase
Hoʻohana ʻia kēia kit no ka ʻike qualitative o OXA-23 carbapenemases i hana ʻia i nā laʻana bacterial i loaʻa ma hope o ka moʻomeheu in vitro.
-
Ho'āʻo CRP/SAA Hui
Hoʻohana ʻia kēia kit no ka ʻike in vitro quantitative o ka C-reactive protein (CRP) a me ka serum amyloid A (SAA) i loko o ka serum kanaka, plasma a i ʻole nā mea hoʻohālike koko holoʻokoʻa.
-
Hoʻohui ʻia ʻo PCT/IL-6
Hoʻohana ʻia ka kit no ka ʻike nui ʻana o ka neʻe ʻana o ka procalcitonin (PCT) a me ka interleukin-6 (IL-6) i loko o ka serum kanaka, plasma a i ʻole nā mea hoʻohālike koko holoʻokoʻa in vitro.
-
18 Nā ʻano o ke kanaka papilloma virus nucleic acid kiʻekiʻe
He kūpono kēia pahu no ka ʻike in vitro qualitative o 18 mau ʻano o nā maʻi papilloma kanaka (HPV) (HPV16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 82) nā ʻāpana nucleic acid kikoʻī i loko o ka mimi kāne / wahine a me nā pūnaewele exfoliated cervical wahine a me ka HPV 16/18 type.
-
Klebsiella Pneumoniae, Acinetobacter Baumannii a me Pseudomonas Aeruginosa a me Drug Resistance Genes (KPC, NDM, OXA48 a me IMP) Multiplex
Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o Klebsiella pneumoniae (KPN), Acinetobacter baumannii (Aba), Pseudomonas aeruginosa (PA) a me ʻehā carbapenem resistance genes (ʻo ia hoʻi ʻo KPC, NDM, OXA48 a me IMP) i nā laʻana sputum kanaka, e hāʻawi. ke kumu o ke alakaʻi ʻana i ka maʻi maʻi, ka mālama ʻana a me ka lāʻau lapaʻau no nā maʻi i manaʻo ʻia he maʻi bacterial.
-
Mycoplasma Pneumoniae （MP）
Hoʻohana ʻia kēia huahana no ka ʻike in vitro qualitative o Mycoplasma pneumoniae (MP) nucleic acid i loko o ka sputum kanaka a me nā laʻana oropharyngeal swab.
